A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532 ↗

Phase 1 Active not recruiting 40 enrolled Daiichi Sankyo

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and tolerability of DS-1055a in participants with relapsed or refractory locally advanced or metastatic solid tumors for which no standard treatment is available.

Timeline

Start: 2020-10-09
Primary completion: 2027-07-01
Completion: 2027-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DS-1055a	Unknown	—	Intravenous

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

Summary

Timeline

Drugs

Indications